FDA Withdraws Direct-To-Consumer Ad Guidance, As It Develops Social Media Documents
This article was originally published in The Gray Sheet
Executive Summary
Agency reps updated stakeholders on guidance development efforts related to advertising and promotion during a Food and Drug Law Institute conference in Washington, D.C.